Find the latest pharmaceutical market place for formulations enquiry about Mebeverine on PharmaCompass.com.

india-flag Flag

Various Finished Dosage Formulations needed in India [ENA19184]

A company that focuses on manufacturing, development, marketing & distribution of branded and generic FDFs is looking for suppliers of Various Finished Formulations. The supplier must support this enquiry with relevant dossiers.
1. Mebeverine (200 mg) ER Capsule
4. Nifedipine (30 mg) ER Capsule
5. Nifedipine (60 mg) ER Capsule
6. Nifedipine (90 mg) ER Capsule

Reply

12 Mar 2024

Various Finished Dosage Formulations needed in Iran [ENA13246]

A leading company based in India that specializes in manufacturing, marketing, and distribution of medical devices is looking for suppliers of Various Finished Dosage Formulations for commercial purpose.
1. Naproxen (500 mg) Tablets. The required quantity is 21,200 units.
2. Mebeverine (135 mg) Tablets. The required quantity is 19,000 units.
3. Prednisolone (5 mg) Tablets. The required quantity is 18,250 units.
4. Permethrin (5%) Creams. The required quantity is 17,500 units.

Reply

08 Apr 2022

saudiarabiapng-1555324364png-1605701218 Flag

Various Finished Dosage Formulations needed in the UAE [ENA10176]

A company that deals in human medical supplies, veterinary medicines and supplements and medical services & hospitals is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The required quantity initially is 10,000 units and later 25,000 - 50,000 units/ annum from each. The supplier must be registered in the UAE.
1. Doxylamine Succinate (10 mg or 20 mg) + Pyridoxine (10 mg or 20 mg) + Folic Acid (2.5 mg or 5 mg) Tablets or Capsules.
2. Benzydamine Hydrochloride (0.15% w/v in 125 ml or 200 ml) Mouthwash
3. Sodium Aescinate (20 mg) Tablets
4. Mebeverine HCl (200 mg) Tablets or Capsules

Reply

09 Apr 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA10012]

Szpital Lipno Sp. z o.o. is looking for supplies of Various Finished Dosage Formulations. The deadline is 31-March-2021.
1. Drotaverine (40 mg) Tablets. The required quantity is 5,300 units.
2. Drotaverine (40 mg/ 2 ml) Solution for Shock. The required quantity is 2,400 units.
3. Loperamide (2 mg) Tablets. The required quantity is 3,900 units.
4. Mebeverine (135 mg) Tablets. The required quantity is 240 units.
5. Acarbose (50 mg) Tablets. The required quantity is 750 units.
6. Empagliflozin (10 mg) Tablets. The required quantity is 750 units.
7. Gliclazide (60 mg) Tablets with Prolonged Release. The required quantity is 2,484 units.
8. Metformin (850 mg, 1000 mg and 500 mg) Tablets. The required quantity is 4,950 units, 5,160 units and 6,570 units respectively.
9. Potassium Chloride (391 mg) Tablets with Prolonged Release. The required quantity is 25,920 units.
10. Thiamine (25 mg) Tablets. The required quantity is 31,500 units.

Reply

22 Mar 2021

In-Licensing Opportunity// Partners needed for Oral Dosage Forms of Mebeverine, Memantine, Metformin & Glicazide ...

A Switzerland-based, international company, focused on marketing products in Eastern Europe and CIS countries is interested in finding partners for Mebeverine Hydrochloride (135 MG Tablets), Memantine Hydrochloride (5 and 10 MG Film Coated Tablets), Metformin Hydrochloride (500 MG Prolonged Tablets), Gliclazide (60 MG Tablets).

Reply

28 Jan 2016